west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "Research advance" 5 results
  • RESEARCH ADVANCE OF TREATMENT OF PERIPHERAL NERVE INJURY WITH NEUROMUSCULAR ELECTRICSTIMULATION

    Objective  To review researches of treatment of peripheral nerve injury with neuromuscular electrical stimulation (NMES) regarding mechanism, parameters, and cl inical appl ication at home and abroad. Methods The latest original l iterature concerning treatment of peri pheral nerve injury with NMES was extensively reviewed. Results NMES should be used under individual parameters and proper mode of stimulation at early stage of injury. It could promote nerve regeneration and prevent muscle atrophy. Conclusion NMES plays an important role in cl inical appl ication of treating peripheral nerve injury, and implantable stimulation will be the future.

    Release date:2016-08-31 05:48 Export PDF Favorites Scan
  • RESEARCH ADVANCE OF ROLE OF INHIBITOR OF DIFFERENTIATION 2 IN SKELETAL MUSCLE REGENERATION

    Objective To review researches of the role of inhibitorof differentiation 2(Id2) in skeletal muscle regeneration. Methods The latest original literature concerning Id2 and its role in skeletal muscle regeneration was extensively reviewed. Results Id2 could form heterodimers by combining with E protein to prevent myogenic regulatory factors (MRFs) forming heterodimers by combining with E protein, to inhibit the transcription activity of MRFs anddifferentiation of skeletal muscle cell. Conclusion Id2 plays an important role in skeletal muscle regeneration.

    Release date:2016-09-01 09:22 Export PDF Favorites Scan
  • RESEARCH ADVANCE IN REPAIR OF PERIPHERAL NERVE DEFECT WITH ACELLULAR NERVE ALLOGRAFT

    Objective To investigate the research advance in repair of the peripheral nerve defect with an acellular nerve allograft. Methods The recent related literature was extensively and comprehensively reviewed. The methods and the effects of the allografts with acellular nerves were analyzed. Results The immunogenicity of the allograft was more significantly relieved by the chemical treatment than by the physicaltreatment. The effect of the chemical treatment on the axon regeneration was better than that of the physical treatment. Conclusion Because of the limitation of the host Schwann cell translation in the longsegment acellular nerve allografts, the effect of Schwann cells is not satisfactory and regeneration of the nerve is limited. So, the recellularized treatment with some related measures can enhance the host Schwann cell translation so that this problem can be solved. 

    Release date:2016-09-01 09:23 Export PDF Favorites Scan
  • ADVANCES IN PERIPHERAL NERVE ALLOGRAFT

    Objective To investigate the research advances of the peripheral nerve allograft.Methods The recent articles on peripheral nerve allograft were reviewed extensively. The treatments of allograft and host were analyzed. Results The immunogenicity of allograft was relieved by the physical,chemical or biological treatments; the immunosuppressive therapy makes the rejection relieved and the regeneration of axon accelerated. Conclusion The effect of peripheral nerve allograft is inferior to autograft. If the immunologic tolerance are inducedsuccessfully, the problem shall be solved.

    Release date:2016-09-01 09:33 Export PDF Favorites Scan
  • Research advances in embolic stroke of undetermined source

    In 2014, the new concept of embolic stroke of undetermined source (ESUS) was first proposed by cryptogenic stroke/ESUS International Working Group. In the past 5 years, related clinical researches of ESUS have been deepened, and the results of many large clinical studies have been published. However, the guiding significance of this new concept to clinical practice is still controversial. By reviewing the background, diagnostic criteria, assessment, common emboli sources, anticoagulant therapy research advances and related limitations of ESUS, and analyzing the possible causes of negative anticoagulant therapy results, we explored the clinical value of this new classification.

    Release date:2019-11-25 04:42 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content